System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Giovanni Barosi is an expert in Hematology at Policlinico San Matteo Fondazione (Italy). As of October 2026, ScienceLeadR ranks Giovanni Barosi in the top 1% of experts worldwide for Anemia. Giovanni Barosi has authored 520 publications, the most recent in 2026, and is an investigator in 4 clinical trials. SLR score: 1,994 (community average: 125). How the SLR is computed.

LeadR Profile

Giovanni Barosi Policlinico San Matteo Fondazione Italy
1 994 ScienceLeadR Reputation 1994

Unlock

Register Login
Network Map

Hematology

Subspecialties: Oncology - Transplantation - Infectiology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 1976 - 2026
Source: PubMed

Policlinico San Matteo Fondazione

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 520

Citations

Citations: 29 587 1st author: 107 Last author: 101 Unique author: 15

Main journals

Blood 151
Haematologica 69
Br J Haematol 33
Leukemia 33
J Clin Oncol 19

Best Journals

Lancet 4
N Engl J Med 3
Ann Oncol 2

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Predicting long-term survival in primary myelofibrosis.
PMID 42897234 — bone marrow, anemia, fibrosis, leukemia, diagnosis, blood platelets, primary myelofibrosis		Leukemia20260
Understanding the link between PMN-MDSCs and CXCL8-CXCR1/2 axis in primary myelofibrosis.
PMID 42222338 — cells, myeloid-derived suppressor cells, neoplasms, interleukin-8, primary myelofibrosis		Front Cell Dev Biol20260
Response to Comment on: "Clonal megakaryocyte dysplasia with normal blood values: a covert, thrombosis-prone, early myeloproliferative neoplasm.".
PMID 42163773 — megakaryocytes, hematology, blood, neoplasms, thrombosis		Haematologica20260
Are Myeloproliferative Neoplasms-Unclassifiable Really Unclassifiable?
PMID 41960215 — bone marrow, neoplasms		EJHaem20260
Ph-chromosome-negative myeloproliferative neoplasms: clonal dynamics are the name of the game.
PMID 41813557 — cells, hematology, blood, neoplasms, clonal evolution, blood cells, names, chromosomes		Blood Rev20260

Clinical Studies 4

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 3 3
Phase 2 1

By status:

Completed 3
Terminated 1

By type:

Interventional 4

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 0
multicentric5to9 0
multicentricup10 4

Main Topics

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS